Core Viewpoint - Southpoint Capital Advisors LP has disposed of 1,000,000 common shares of Fennec Pharmaceuticals Inc., representing approximately 2.93% of the outstanding shares, for investment purposes [1][3]. Group 1: Share Transaction Details - The common shares were sold at a price of USD$7.50 per share [2]. - Following the sale, Southpoint now controls 2.7 million common shares, which is about 8% of the outstanding shares [2]. Group 2: Future Ownership Intentions - Southpoint may adjust its beneficial ownership of common shares depending on market conditions through various means such as market transactions or private agreements [3].

Core Insights - Berkshire Hathaway Inc. acquired 17.9 million shares of Alphabet Inc., valued at approximately $4.9 billion, representing 0.31% of outstanding shares [1] - Berkshire's cash reserves reached a record $382 billion, prompting investments in Occidental Petroleum Corp. and UnitedHealth Group Inc. [2] - Berkshire reduced its Apple stake by 15%, now valued at $60.7 billion, while still holding nearly 25% of its equity portfolio in Apple [3] - The company sold 37.2 million shares of Bank of America, maintaining a 7.7% stake in the firm [3] - Berkshire exited its position in D.R. Horton Inc., a US home builder [3]